MANNKIND CORP Deferred Tax Assets, Tax Deferred Expense
MANNKIND CORP (MNKD) had Deferred Tax Assets, Tax Deferred Expense of $251.00 thousand as of 2015-12-31, per its 10-K filed 2016-03-15.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsTaxDeferredExpense · last filed 2016-03-15
- 2015-12-31: Deferred Tax Assets, Tax Deferred Expense $251.00K.
- 2014-12-31: Deferred Tax Assets, Tax Deferred Expense $768.00K.
- 2013-12-31: Deferred Tax Assets, Tax Deferred Expense $3.58M.
- 2012-12-31: Deferred Tax Assets, Tax Deferred Expense $2.92M.
| Period end | Deferred Tax Assets, Tax Deferred Expense |
|---|---|
| 2015-12-31 | $251.00K 10-K · filed 2016-03-15 |
| 2014-12-31 | $768.00K 10-K · filed 2016-03-15 |
| 2013-12-31 | $3.58M 10-K · filed 2015-03-02 |
| 2012-12-31 | $2.92M 10-K · filed 2014-03-03 |
| 2011-12-31 | $2.83M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |